Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba

被引:37
作者
Martin-Navarro, C. M. [1 ,2 ]
Lopez-Arencibia, A. [1 ]
Arnalich-Montiel, F. [3 ]
Valladares, B. [1 ]
Pinero, J. E. [1 ]
Lorenzo-Morales, J. [1 ]
机构
[1] Univ La Laguna, Univ Inst Trop Dis & Publ Hlth Canary Isl, Tenerife 38203, Canary Islands, Spain
[2] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9YL, Midlothian, Scotland
[3] Hosp Ramon & Cajal, Dept Ophthalmol, Cornea Unit, E-28034 Madrid, Spain
关键词
Acanthamoeba; Acanthamoeba keratitis; Therapy; Moxifloxacin; Voriconazole; FREE-LIVING AMEBAS; GENE SEQUENCE TYPE; POLYHEXAMETHYLENE BIGUANIDE; KERATITIS; SPP; IDENTIFICATION; CHLORHEXIDINE; PATHOGENESIS; PENETRATION; RESISTANCE;
D O I
10.1007/s00417-013-2371-y
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Acanthamoeba is an opportunistic pathogen which is the causal agent of a sight-threatening ulceration of the cornea known as "Acanthamoeba keratitis" (AK) and, more rarely, an infection of the central nervous system called "granulomatous amoebic encephalitis" (GAE). The symptoms of AK are non-specific, and so it can be misdiagnosed as a viral, bacterial, or fungal keratitis. Furthermore, current therapeutic measures against AK are arduous, and show limited efficacy against the cyst stage of Acanthamoeba. Moxifloxacin, a fourth generation fluoroquinolone, has been used with other drugs to treat GAE, but its efficacy as a treatment for AK is not known. Voriconazole has been used to treat AK; however, its cysticidal efficacy is not known. Both drugs are commercially available as eye-drops. The aim of this study was to evaluate the in-vitro activity of these eye-drops against Acanthamoeba compared to two reference drugs (chlorhexidine and amphotericin B) which are currently used to treat AK and GAE. The sensitivity of two clinical and one type strain of Acanthamoeba to the commercial concentrations of the four drugs was evaluated with a colorimetric assay. Mature cysts were incubated with voriconazole to determine their sensitivity to this drug. The effects on cell proliferation and cell toxicity were determined using standard procedures with commercial kits. The four compounds were active against the Acanthamoeba strains in this study. Although it prevented encystation, moxifloxacin's amoebicidal activity was low. Voriconazole activity was greater than that of the other drugs, even at a concentration lower than in commercial eye drops. It was effective against cysts and decreased cell proliferation, with low cellular cytotoxicity. Voriconazole could be used against AK as a first-line treatment or in combination. Moxifloxacin is an interesting adjuvant to consider as it is effectively prevents encystation of the amoeba which often complicates infection resolution. In addition, moxifloxacin is effective in preventing secondary bacterial infections.
引用
收藏
页码:2111 / 2117
页数:7
相关论文
共 47 条
[1]  
Aksozek A, 2002, J PARASITOL, V88, P621, DOI 10.1645/0022-3395(2002)088[0621:ROACCT]2.0.CO
[2]  
2
[3]   Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp. [J].
Anquetin, G ;
Rouquayrol, M ;
Mahmoudi, N ;
Santillana-Hayat, M ;
Gozalbes, R ;
Greiner, J ;
Farhati, K ;
Derouin, F ;
Guedj, R ;
Vierling, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) :2773-2776
[4]   Treatment With Voriconazole in 3 Eyes With Resistant Acanthamoeba Keratitis [J].
Bang, Stacy ;
Edell, Erica ;
Eghrari, Allen O. ;
Gottsch, John D. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (01) :66-69
[5]  
Banich AM, 2003, INVEST OPHTH VIS SCI, V44, pU317
[6]   VIABILITY OF ACANTHAMOEBA CYSTS IN OPHTHALMIC SOLUTIONS [J].
BRANDT, FH ;
WARE, DA ;
VISVESVARA, GS .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1989, 55 (05) :1144-1146
[7]   Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects [J].
Charvalos, E ;
Tzatzarakis, MN ;
Van Bambeke, F ;
Tulkens, PM ;
Tsatsakis, AM ;
Tzanakakis, GN ;
Mingeot-Leclercq, MP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (02) :236-244
[8]   Phylogenetic evidence for a new genotype of Acanthamoeba (Amoebozoa, Acanthamoebida) [J].
Corsaro, Daniele ;
Venditti, Danielle .
PARASITOLOGY RESEARCH, 2010, 107 (01) :233-238
[9]   Acanthamoeba Keratitis: Diagnosis and Treatment Update 2009 [J].
Dart, John K. G. ;
Saw, Valerie P. J. ;
Kilvington, Simon .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (04) :487-499
[10]   MICROBIAL-CONTAMINATION OF CONTACT-LENS CASES IN THE WEST OF SCOTLAND [J].
DEVONSHIRE, P ;
MUNRO, FA ;
ABERNETHY, C ;
CLARK, BJ .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (01) :41-45